Table 4.
PFGE strain | Also detected without qnrS | First detection | MIC ENRO [mg/L] | ECOR group | |
---|---|---|---|---|---|
Source | Day | ||||
I-12 | yes | EG (CG)a | 35 (11) | 0.03 (0.06) | A |
I-21 | no | EG | 54 | 1 | A |
I-25 | yes | CG (En) | 42 (5) | 8 (0.03) | A |
I-28 | no | EG | 54 | 1 | A |
I-31 | no | CG | 54 | 1 | B1 |
I-34 | no | EG | 21 | 1 | B1 |
I-37 | yes | EG (EG) | 54 (54) | 1 (0.03) | A |
I-38 | yes | CG (CG) | 54 (18) | 2 (n.t.) | A |
I-41 | yes | EG (CG) | 54 (21) | 1 (n.t.) | A |
I-45 | no | EG | 54 | 1 | A |
I-51 | yes | EG (CG) | 54 (11) | 1 (n.t.) | A |
I-56 | no | CG | 54 | 1 | A |
EG experimental group, CG control group, En environment, PFGE Pulsed-Field Gel Electrophoresis, n.t. not tested, ENRO Enrofloxacin
aNumber in brackets apply to the same PFGE strain without qnrS